Zhanping Lu

569 total citations
16 papers, 459 citations indexed

About

Zhanping Lu is a scholar working on Molecular Biology, Cancer Research and Cell Biology. According to data from OpenAlex, Zhanping Lu has authored 16 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 5 papers in Cancer Research and 3 papers in Cell Biology. Recurrent topics in Zhanping Lu's work include Epigenetics and DNA Methylation (6 papers), MicroRNA in disease regulation (4 papers) and Genomics and Chromatin Dynamics (4 papers). Zhanping Lu is often cited by papers focused on Epigenetics and DNA Methylation (6 papers), MicroRNA in disease regulation (4 papers) and Genomics and Chromatin Dynamics (4 papers). Zhanping Lu collaborates with scholars based in China, United States and Russia. Zhanping Lu's co-authors include Lihong Ye, Xiaodong Zhang, Fabao Liu, Zelin Xiao, Ming Cui, Weiping Li, Zhe Yang, Yuen Gao, Jiong Li and Weiying Zhang and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Development.

In The Last Decade

Zhanping Lu

15 papers receiving 454 citations

Peers

Zhanping Lu
Yingru Zhi China
Yu-Feng Yang China
Pihai Gong China
Manuela Lanzafame Italy
Meina Yan China
Nerea Matamala Spain
Jovanna González Spain
Wei-Chao Hao China
Yingru Zhi China
Zhanping Lu
Citations per year, relative to Zhanping Lu Zhanping Lu (= 1×) peers Yingru Zhi

Countries citing papers authored by Zhanping Lu

Since Specialization
Citations

This map shows the geographic impact of Zhanping Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhanping Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhanping Lu more than expected).

Fields of papers citing papers by Zhanping Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhanping Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhanping Lu. The network helps show where Zhanping Lu may publish in the future.

Co-authorship network of co-authors of Zhanping Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhanping Lu. A scholar is included among the top collaborators of Zhanping Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhanping Lu. Zhanping Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Lu, Zhanping, Yinghua Wang, Peng Liu, et al.. (2025). Chromatin factor YY1 controls fetal hematopoietic stem cell migration and engraftment in mice. Journal of Clinical Investigation. 135(19).
2.
Lu, Zhanping, Yinghua Wang, Peng Liu, et al.. (2024). Yin Yang 1 regulates cohesin complex protein SMC3 in mouse hematopoietic stem cells. Blood Advances. 8(12). 3076–3091. 6 indexed citations
3.
Wang, Tingye, Feng Li, & Zhanping Lu. (2023). Ultra-conserved RNA: a novel biological tool with diagnostic and therapeutic potential. Discover Oncology. 14(1). 41–41. 1 indexed citations
4.
Fu, Guoping, Zhanping Lu, Rene Welch, et al.. (2021). A lineage-specific requirement for YY1 Polycomb Group protein function in early T cell development. Development. 148(7). 7 indexed citations
5.
Fu, Guoping, et al.. (2020). A Lineage-Specific Requirement for YY1 Polycomb Group Protein Function in Early T Cell Development. Blood. 136(Supplement 1). 35–35. 1 indexed citations
6.
Lu, Zhanping, et al.. (2019). Pevonedistat targeted therapy inhibits canine melanoma cell growth through induction of DNA re‐replication and senescence. Veterinary and Comparative Oncology. 18(3). 269–280. 6 indexed citations
7.
Lu, Zhanping, Courtney C. Hong, Guangyao Kong, et al.. (2018). Polycomb Group Protein YY1 Is an Essential Regulator of Hematopoietic Stem Cell Quiescence. Cell Reports. 22(6). 1545–1559. 36 indexed citations
8.
Lu, Zhanping, et al.. (2018). YY1 Controls Hematopoietic Stem Cell Quiescence By Repressing Cohesin Expression. Blood. 132(Supplement 1). 3831–3831. 1 indexed citations
9.
Zhang, Weiying, Zhanping Lu, Yuen Gao, et al.. (2015). MiR-520b suppresses proliferation of hepatoma cells through targeting ten-eleven translocation 1 (TET1) mRNA. Biochemical and Biophysical Research Communications. 460(3). 793–798. 25 indexed citations
10.
Lu, Zhanping, Weiying Zhang, Shan Gao, et al.. (2015). MiR-506 suppresses liver cancer angiogenesis through targeting sphingosine kinase 1 (SPHK1) mRNA. Biochemical and Biophysical Research Communications. 468(1-2). 8–13. 45 indexed citations
11.
Gao, Yuen, Yuan Wang, Jinyan Feng, et al.. (2015). A hairpin within YAP mRNA 3′UTR functions in regulation at post-transcription level. Biochemical and Biophysical Research Communications. 459(2). 306–312. 6 indexed citations
12.
Lu, Zhanping, Zelin Xiao, Zhe Yang, et al.. (2015). Hepatitis B virus X protein promotes human hepatoma cell growth via upregulation of transcription factor AP2α and sphingosine kinase 1. Acta Pharmacologica Sinica. 36(10). 1228–1236. 21 indexed citations
13.
Lu, Zhanping, Zelin Xiao, Fabao Liu, et al.. (2015). Long non-coding RNA HULC promotes tumor angiogenesis in liver cancer by up-regulating sphingosine kinase 1 (SPHK1). Oncotarget. 7(1). 241–254. 167 indexed citations
14.
Zhang, Weiying, Zhanping Lu, Guangyao Kong, et al.. (2014). Hepatitis B virus X protein accelerates hepatocarcinogenesis with partner survivin through modulating miR-520b and HBXIP. Molecular Cancer. 13(1). 128–128. 51 indexed citations
15.
Zhang, Tao, Junping Zhang, Ming Cui, et al.. (2013). Hepatitis B Virus X Protein Inhibits Tumor Suppressor miR-205 through Inducing Hypermethylation of miR-205 Promoter to Enhance Carcinogenesis. Neoplasia. 15(11). 1282–IN26. 80 indexed citations
16.
Lu, Zhanping & Matthew B. Wolf. (1993). Platelet activating factor-induced microvascular permeability increases in the cat hindlimb.. PubMed. 41(1). 8–18. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yingru Zhi Breakdown of academic impact, for papers by Yu-Feng Yang Breakdown of academic impact, for papers by Pihai Gong Breakdown of academic impact, for papers by Manuela Lanzafame Breakdown of academic impact, for papers by Meina Yan Breakdown of academic impact, for papers by Nerea Matamala Breakdown of academic impact, for papers by Jovanna González Breakdown of academic impact, for papers by Wei-Chao Hao
Rankless by CCL
2026